Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

23Andme Holding Co. (ME)

23Andme Holding Co. (ME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

23Andme Holding Co. 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 USA

www.23andme.com P: 650-938-6300

Description:

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.

Key Statistics

Overview:

Market Capitalization, $K 193,939
Enterprise Value, $K -194,311
Shares Outstanding, K 482,917
Annual Sales, $ 299,490 K
Annual Net Income, $ -311,660 K
Last Quarter Sales, $ 44,750 K
Last Quarter Net Income, $ -277,980 K
EBIT, $ -340,070 K
EBITDA, $ -303,570 K
60-Month Beta 1.27
% of Insider Shareholders 27.55%
% of Institutional Shareholders 36.10%
Float, K 349,873
% Float 72.45%
Short Volume Ratio 0.77

Growth:

1-Year Return -81.75%
3-Year Return -95.98%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 02/07/24
Latest Earnings Date 05/23/24
Earnings Per Share ttm -0.69
EPS Growth vs. Prev Qtr -6.25%
EPS Growth vs. Prev Year 15.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ME Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -52.99%
Return-on-Assets % -39.32%
Profit Margin % -104.06%
Debt/Equity 0.00
Price/Sales 0.76
Price/Cash Flow N/A
Price/Book 0.57
Book Value/Share 0.78
Interest Coverage -0.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar